Bastian Czogalla - Concepedia

Author

Bastian Czogalla

Ludwig-Maximilians-Universität München ORCID

Also Known As

B Czogalla, B. Czogalla, Bastian Czogalla, Czogalla B, Czogalla, Bastian

142

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Ludwig-Maximilians-Universität München LMU Klinikum University Hospital Augsburg Heidelberg University Deutschen Konsortium für Translationale Krebsforschung

About

Bastian Czogalla is an author at Ludwig-Maximilians-Universität München specializing in medicine, ovarian cancer, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	320
2	Cell Biology	3	3	53
3	Engineering	1	1	45
4	Public Health	1	1	16
5	Biostatistics	1	1	45

Bastian Czogalla

Publications

773

Citations

H-Index

Page 1

	Year	Citations
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García, The Lancet OncologyCervical CancerMetronomic TherapyPathologyRecurrent Cervical Cancer	2023	175
Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile Mingjun Zheng, Heather Mullikin, Anna Hester, International Journal of Molecular Sciences EngineeringGynecologyPathologyLimma PackageGene Expression Profiling	2020	45
The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro Nan Han, Sabine Heublein, Udo Jeschke, Cells Histone H3Lysine 4Epigenetic ChangeGynecologyEpigenetics	2021	30
Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients Bastian Czogalla, Maja Kahaly, Doris Mayr, International Journal of Molecular Sciences	2018	29
PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva Bastian Czogalla, Deborah L. Pham, Fabian Trillsch, Journal of Cancer Research and Clinical Oncology	2020	29
Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients Eileen Deuster, Doris Mayr, Anna Hester, International Journal of Molecular Sciences	2019	28
M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis Susann Badmann, Sabine Heublein, Doris Mayr, Cells	2020	28
High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer Susanne Beyer, Lena Müller, Sophie Mitter, Journal of Cancer Research and Clinical Oncology	2022	27
Cytoplasmic VDR expression as an independent risk factor for ovarian cancer Bastian Czogalla, Eileen Deuster, Yue Liao, Histochemistry and Cell Biology	2020	25
β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation Bastian Czogalla, Alexandra Partenheimer, Udo Jeschke, Frontiers in Endocrinology	2020	22

Page 1